A brief look: Cancer genomic medicine at the 2013 Annual Meeting of the American Society of Clinical Oncology®

A few highly provocative abstracts presented at the 2013 Annual Meeting of the American Society of Clinical Oncology® demonstrate how a shift toward more molecular-targeted therapies is changing the paradigm of cancer medicine. Although these abstracts may not have been the most unique or important molecular studies presented at the meeting, they clearly emphasize the scope and complexity of this rapidly evolving arena. Read more here.

First time users may be asked to sign in.